BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 7827397)

  • 1. Do calcium channel blockers have renal protective effects?
    Reams GP
    Drugs Aging; 1994 Oct; 5(4):263-87. PubMed ID: 7827397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel blockers: do they offer renal protection?
    Reams GP
    J Hum Hypertens; 1993 Jun; 7(3):211-9. PubMed ID: 8345486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal vascular effects of calcium channel blockers in hypertension.
    Benstein JA; Dworkin LD
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):305S-312S. PubMed ID: 2078317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal effects of calcium antagonists with special reference to manidipine hydrochloride.
    Rodicio JL
    Blood Press Suppl; 1996; 5():10-5. PubMed ID: 8973787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of calcium antagonists on the hypertensive kidney.
    Reams GP; Bauer JH
    Cardiovasc Drugs Ther; 1990 Oct; 4(5):1331-5. PubMed ID: 2278868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of verapamil on cardio- and hemodynamics in rats with various models of hypertension].
    Spasov AA; Gurbanov KG; Seredintseva NV; Paperno AA
    Eksp Klin Farmakol; 1997; 60(3):30-3. PubMed ID: 9324394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal functional reserve in calcium channel blocker-treated hypertensive recipients of kidney transplant.
    Tack I; Rostaing L; Tran-Van T; Lloveras JJ; Durand D; Suc JM; Ader JL
    Nephrol Dial Transplant; 1995; 10 Suppl 6():117-9. PubMed ID: 8524480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
    Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the two new calcium channel blockers mebudipine and dibudipine in comparison to amlodipine on vascular flow of isolated kidney of diabetic rat.
    Sepehr-Ara L; Sepehr-Ara M; Mahmoudian M
    Acta Physiol Hung; 2010 Sep; 97(3):281-9. PubMed ID: 20843766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of calcium antagonists on glomerular hemodynamics and structure in experimental hypertension.
    Dworkin LD
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):89-93. PubMed ID: 2024683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydropyridine calcium antagonists and renal function in hypertensive kidney transplant recipients.
    Rump LC; Oberhauser V; Schwertfeger E; Speidel L; Zimmerhackl L; Kirste G; Grotz W
    J Hypertens; 2000 Aug; 18(8):1115-9. PubMed ID: 10954004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination antihypertensive therapy in the treatment of diabetic nephropathy.
    Boner G; Cao Z; Cooper ME
    Diabetes Technol Ther; 2002; 4(3):313-21. PubMed ID: 12165170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of calcium channel antagonists on renal function in hypertensive heart transplant recipients.
    Bunke M; Ganzel B
    J Heart Lung Transplant; 1992; 11(6):1194-9. PubMed ID: 1457446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of calcium channel blockade on adrenergically induced renal vasoconstriction in rat models of renal impairment.
    Khan AH; Sattar MA; Abdullah NA; Johns EJ
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):501-8. PubMed ID: 19673932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion.
    Ruggenenti P; Perico N; Mosconi L; Gaspari F; Benigni A; Amuchastegui CS; Bruzzi I; Remuzzi G
    Kidney Int; 1993 Mar; 43(3):706-11. PubMed ID: 8455370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydropyridine calcium channel blockers and renal disease.
    Robles NR; Fici F; Grassi G
    Hypertens Res; 2017 Jan; 40(1):21-28. PubMed ID: 27412800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in renal function by felodipine during cyclosporine treatment in acute and short-term studies.
    Pedersen EB; Madsen JK; Sørensen SS; Zachariae H
    Kidney Int Suppl; 1996 Jun; 55():S94-6. PubMed ID: 8743522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of calcium antagonists in renal patients: therapeutic benefit or medical malpractice?
    Nigbor DA; Lewis JB
    Curr Hypertens Rep; 2003 Oct; 5(5):430-6. PubMed ID: 12948437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.